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The nocardioazine natural products are uniquely prenylated and
methylated indole alkaloid diketopiperazines (DKPs) that reverse
drug resistance of cancer cell lines. We unveiled the
nocardioazine biosynthetic pathway from a marine actinomycete,
demonstrating that a cyclodipeptide synthase catalyzes cyclo(L-
Trp-L-Trp) DKP precursor formation followed by tailoring of this
DKP via a novel racemase, prenyltransferase, and
methyltransferase to yield nocardioazine B. These results highlight
the aptitude of bacteria for chemical synthesis and offer new
enzymatic tools for crafting complex organic molecules.
Fig. 1. DKP Structures and genes. (a) Cyclo(L-Trp-L-Trp) (cWW)
[DKP assembled by the NozA CDPS from noz cluster 13],
nocardioazine B, and nocardioazine A structures. (b) Hypothesized
nocardioazine gene clusters from Nocardiopsis sp.
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Fig. 6. LC-MS Analysis of MT Enzyme Activity Assays.
(a) No methylation evident with DD-cWW as substrate.
(b) No methylation evident with LL-cWW as substrate.
(c) Presence of nocardioazine B indicates double
methylation of prenyl-cWW. Observed methylation of
prenyl-cWW but not of DD/LL-cWW supports that
prenylation of cWW occurs prior to methylation during
nocardioazine assembly.
Fig. 7. LC-MS Analysis of MT Time-Course
Experiment. Rapid drop-off in prenyl-cWW in
conjunction with rise in mono-methylated
intermediates followed by rise in dual-methylated
nocardioazine B indicates the sufficiency of these
components in the nocardioazine B pathway. Error
bars indicate ±1σ of n=2 replicates.
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• Actinomycetes have been a key resource in natural product
discovery since the 1950’s1. Diketopiperazines (DKPs) are one
class of products produced by these bacteria.
• Molecules with a DKP scaffold are structurally diverse owing to
the multiple amino acids that can be incorporated into the
scaffold as well as tailoring of the scaffold2,3. This diversity and
demonstrated array of biological activities4 makes these
especially interesting compounds.
• Nocardioazines (Fig. 1a) are one DKP example and have been
shown to inhibit drug resistance in cancer cell lines5. We
hypothesized that a cluster of genes encoding three enzymes
(Fig. 1b) works in conjunction with the products of either of two
cyclodipeptide synthases (CDPS) present in a Nocardiopsis sp.
actinomycete to yield the nocardioazines3.
Fig. 3. LC-MS Analysis of Nocardioazine B Production for (A) Streptomyces M1152
and (B) Streptomyces TK24 carrying either noz1 cluster or both noz1+2 clusters. No
nocardioazine B was produced with only one gene cluster (+noz1 -noz2). Nocardioazine B
was only produced when both gene clusters were present (+noz1+noz2), as indicated by
comparison with nocardioazine B standard at the retention time and molecular ion m/z
469. This links both of the two noz gene clusters (Fig. 1b) to nocardioazine B assembly.
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Fig. 8. Proposed Nocardioazine Pathway. This marks the first report of a MT
catalyzing both N- and C-methylation of any natural product.
• This work establishes that noz 1 + 2 gene clusters encode nocardioazine
assembly (Fig. 3). Most bacterial natural products are assembled by one gene 
cluster, making the nocardioazine pathway unusual.
• MT activity assays (Fig. 6) show that MT acts as the final enzyme in the 
pathway.
• These results set the stage for biocatalytic application of Noz enzymes to yield 
new DKPs with cost effective, green methods.
• Traditional DKP synthesis methods require a complex system of 
reactions in excess of 20 steps, specialized equipment/techniques, 
and generate large amounts of hazardous waste in the form of 
solvents6. 
• Biosynthesis uses fewer harmful solvents, often requires only several 
steps, and after initial research investment can produce complex 
molecules with little more than high school lab tools.
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Fig. 5. 1H (Left) and 13C NMR (Right) Spectra for Prenyl-cWW. These 1H and 13C NMR
spectra of isolated prenyl-cWW allows us to propose the molecular structure. Observation of
this intermediate also supports that prenylation comes prior to methylation in the
nocardioazine metabolic pathway.
Fig. 4. Timeline of Nocardioazine B Production
by Streptomyces TK24 and M1152 strains. TK24
was shows to yield more nocardiozine than M1152.
The error bars represent +/- 1 standard deviation
for n=2.
Fig. 2. General research flow. This outline shows the overall method our lab uses
to search out and attempt to understand natural products.
